A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma

Lorena P. Suarez-Kelly, Kala M. Levine, Thomas E. Olencki, Sara E.Martin del Campo, Elizabeth A. Streacker, Taylor R. Brooks, Volodymyr I. Karpa, Joseph Markowitz, Anissa K. Bingman, Susan M. Geyer, Kari L. Kendra, William E. Carson

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)619-629
Number of pages11
JournalCancer Immunology, Immunotherapy
Issue number4
StatePublished - Apr 2 2019

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Cancer Research

Cite this